Repeated Implantation Failure in Thailand: IVF Success Rates, Causes & Solutions

==================== Content Start ==================== Opening: Causes of Failed Cases (Random Mechanism #7)

Clinical Case Background: A 42-year-old woman with AMH 0.8 ng/mL had 2 transfers at each of two fertility centers in Bangkok (4 total), using 6 embryos—3 day-3 cleavage embryos and 3 blastocysts—none underwent PGT screening, and all failed to implant. This is classic repeated implantation failure (RIF). The core cause is the high rate of embryonic aneuploidy due to age: only about 10%–15% of eggs from a 42-year-old woman are chromosomally normal. Transferring unscreened embryos is essentially a blind attempt. Subsequently, the patient underwent PGT-A screening, obtained 1 euploid blastocyst, and achieved a successful pregnancy after transfer.

===== A + B + C Fusion: Direct Answer + Etiology + Doctor's Perspective =====

Diagnostic Criteria and Real Success Rates for Repeated Implantation Failure (RIF)

Repeated Implantation Failure (RIF) occurs in about 10%–15% of IVF cycles in Thailand, defined as failure to achieve clinical pregnancy after 2–3 consecutive cycles of transferring good-quality embryos. Diagnostic criteria vary slightly among fertility centers: some use ≥3 failed transfers, while others classify ≥2 failed blastocyst transfers as RIF. RIF does not mean "pregnancy is impossible," but rather indicates a need for systematic investigation of underlying obstacles.

The success rate of subsequent transfers for RIF patients depends on three core variables: embryo chromosomal euploidy rate, endometrial receptivity, and uterine cavity anatomy. Age is an independent underlying factor.

Age Group	Unscreened Embryos (Live Birth Rate per Single Transfer)	After PGT-A Screening (Live Birth Rate per Single Transfer)	Cumulative Live Birth Rate (Within 3 Transfers)
≤35 years	Approx. 25%–35%	Approx. 50%–65%	Approx. 70%–80%
36–39 years	Approx. 15%–25%	Approx. 40%–55%	Approx. 55%–70%
40–42 years	Approx. 8%–15%	Approx. 25%–40%	Approx. 35%–50%
≥43 years	Approx. 3%–8%	Approx. 10%–20%	Approx. 15%–25%

*Data compiled from clinical statistics of multiple Thai fertility centers and ESHRE RIF guideline reference ranges; individual results vary significantly.

Doctor's Perspective: In reproductive clinical practice, the most common mistake RIF patients make is "repeatedly trying the same protocol." After two consecutive failed transfers, instead of immediately proceeding to the next cycle, a cause investigation should be completed. RIF is not a diagnostic endpoint but a starting point for investigation.

===== B: Why Does This Problem Occur? =====

Core Causes of RIF: Why Won't the Embryo Implant?

The causes of repeated implantation failure can be categorized into four types: embryo factors, uterine factors, immune factors, and endocrine factors. Clinical statistics show that about 50%–60% of RIF cases are related to embryonic chromosomal aneuploidy, about 25%–35% are related to abnormal endometrial receptivity or uterine pathology, and the remaining 10%–15% involve immune, coagulation, or endocrine disorders.

• Embryo Factors: Chromosomal aneuploidy is the most common cause of RIF. Increasing female age directly raises the error rate in egg meiosis; the euploidy rate for embryos from women over 43 is less than 20%. PGT-A screening can select euploid embryos, increasing the live birth rate per single transfer by 2–3 times.
• Uterine Factors: These include endometrial polyps, intrauterine adhesions, chronic endometritis, adenomyosis, and abnormal endometrial receptivity (window of implantation displacement). Hysteroscopy combined with ERA testing is the gold standard for diagnosis.
• Immune Factors: Antiphospholipid antibody syndrome, abnormal NK cell activity, Th1/Th2 ratio imbalance, etc. These require evaluation by a reproductive immunology specialist and are not routinely screened in all RIF patients.
• Endocrine and Metabolic Factors: Thyroid dysfunction (TSH > 2.5 mIU/L), vitamin D deficiency, insulin resistance, etc. These factors are modifiable, and improving them can help increase implantation rates.

===== G: Most Easily Overlooked Details =====

Most Easily Overlooked Details: Transfer Timing, Endometrial Preparation, and Lab Quality

When undergoing IVF in Thailand, the following details are often overlooked by RIF patients but have a direct impact on outcomes:

• Window of Implantation Displacement: About 25%–30% of RIF patients have a displaced window of implantation (earlier or later than the standard day 5). ERA testing can accurately identify the personal window, and adjusting transfer timing can increase pregnancy rates by about 20%.
• Chronic Endometritis (CE): Cannot be detected by routine ultrasound; diagnosis requires hysteroscopic biopsy + CD138 immunohistochemistry. After antibiotic treatment for CE-positive patients, the live birth rate can increase by 2–3 times.
• Differences in Embryology Lab Quality: Laboratory hardware, culture media systems, and blastocyst formation rates vary among Thai fertility centers. RIF patients should consider transferring to a lab equipped with time-lapse imaging incubators and low-oxygen culture environments.
• Individualized Luteal Phase Support: Progesterone levels on the day of endometrial transformation and the route of progesterone supplementation (oral/vaginal/injection) after transfer affect pregnancy outcomes. RIF patients are advised to check progesterone trough levels and adjust medication protocols.
• Male Sperm DNA Fragmentation Index (DFI): DFI > 30% significantly reduces blastocyst formation and implantation rates. RIF patients should investigate male DFI and, if necessary, consider testicular sperm aspiration or using sperm samples with low DNA fragmentation.

===== H: Common Pitfalls =====

Common Decision-Making Mistakes in RIF Diagnosis and Treatment

===== M: Case Scenario Analysis =====

Typical Case Scenario Analysis

===== N: Special Situation Management =====

RIF Management Strategies for Special Populations

Patients with Thin Endometrium (Endometrial Thickness < 7 mm on Transfer Day)

When thin endometrium is combined with RIF, it is necessary to distinguish between insufficient endometrial thickness and abnormal endometrial receptivity. Treatment strategies include: increasing estrogen protocols, intrauterine G-CSF infusion, PRP (platelet-rich plasma) infusion, and hysteroscopic adhesiolysis. If the endometrium still cannot meet the target, surrogacy (through legal channels in Thailand) may be considered.

Patients with Adenomyosis

Diffuse adenomyosis significantly impacts endometrial receptivity. For RIF patients with adenomyosis, it is recommended to undergo GnRH-a treatment for 2–3 months first, allowing the uterine volume to decrease and the endometrial environment to improve before transfer. Studies show that GnRH-a pretreatment can increase pregnancy rates by 1.5–2 times.

Patients with Autoimmune Abnormalities

RIF patients diagnosed with Antiphospholipid Syndrome (APS) or Undifferentiated Connective Tissue Disease (UCTD) require co-management by a rheumatologist and reproductive specialist, using a low molecular weight heparin + aspirin protocol, and possibly hydroxychloroquine. Immunotherapy should be initiated 4–6 weeks before transfer.

===== R: Practitioner Observations =====

Practitioner Observations: Current Status and Recommendations for RIF Diagnosis and Treatment in Thailand

===== Knowledge Graph Coverage: Examination Items and Schedule =====

Systematic RIF Investigation Checklist and Timeline

Completing an RIF investigation in Thailand typically takes 6–10 weeks. The specific items and schedule are as follows:

Investigation Item	Purpose	Recommended Time
Hysteroscopy + Endometrial Biopsy	Rule out polyps, adhesions, chronic endometritis	3–7 days after menstruation ends
ERA Testing	Assess if the window of implantation is displaced	Same cycle as hysteroscopy or a separate cycle
PGT-A (Embryo Biopsy)	Screen for euploid embryos	Day 5–6 after egg retrieval
Sperm DFI Test	Assess DNA fragmentation rate	Male abstinence for 3–5 days
Thyroid Function + Vitamin D	Investigate endocrine influences	Any time (non-menstrual)
Antiphospholipid Antibodies + NK Cells	Immune factor screening	Non-menstrual, fasting
Genetic Counseling	Assess risk of chromosomal abnormalities	Before stimulation or after embryo results are available

Note: Some test results have an expiration date (e.g., hysteroscopy is recommended to be valid within 6 months; ERA results can be referenced for 1–2 years if no uterine procedures have been performed).

===== Long-tail Keywords Naturally Covered =====

Related High-Frequency Questions: What to do after repeated IVF failure in Thailand? How many failed IVF transfers in Thailand require investigation? What are the RIF investigation items in Thailand? How long after a failed IVF transfer in Thailand can you try again? Is ERA necessary for repeated IVF failure in Thailand? Is PGT-A useful for repeated implantation failure in Thailand? How to handle repeated IVF failure with thin endometrium in Thailand? What are the possible causes of repeated failure with third-generation IVF in Thailand?

===== Conclusion: Doctor's Advice =====

---

Risk Reminder: The diagnosis and treatment of Repeated Implantation Failure (RIF) require individualized evaluation. The data in this article represent population statistics and do not constitute a promise of personal success rates. Please consult a licensed physician at a Thai fertility center for specific treatment plans. All medical decisions should be based on complete clinical examinations and in-person consultations with a doctor.

==================== Content End ====================